|
Occult Non-Small Cell Lung Cancer
Current Clinical Trials
Occult non-small cell lung cancer (NSCLC) is defined by the following clinical stage grouping:
In occult lung cancer, a diagnostic evaluation often includes chest x-ray and
selective bronchoscopy with close follow-up (e.g., computed tomographic scan),
when needed, to define the site and nature of the primary tumor; tumors
discovered in this fashion are generally early stage and curable by surgery.
After discovery of the primary tumor, treatment involves establishing
the stage of the tumor. Therapy is identical to that recommended for other NSCLC patients with similar stage disease.
Current Clinical Trials
Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with occult non-small cell lung cancer. The list of clinical trials can be further narrowed by location, drug, intervention, and other criteria.
General information about clinical trials is also available from the NCI Web site.
Back to Top
< Previous Section | Next Section > |
